NLRP3-/- mice have an increased risk of developing CRC liver metastases (131) and caspase-1-deficient mice exhibited more severe tumorigenesis, decreased STAT1 and IL-1β compared with the NLRP3-/- mouse model (132). Here, NLRP3 is linked to colorectal carcinoma.